SARA CLUM: Open Payments
NPI 1205589926 · RAYTOWN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$303 in 9 payments from 5 companies in 2025. Trend: 2023 $383 · 2024 $150 · 2025 $303
Food & beverage: $303
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 1 | $133 |
| Teva Pharmaceuticals USA, Inc. | 3 | $63 |
| ABBVIE INC. | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| Alkermes, Inc. | 1 | $31 |
Products named: INVEGA SUSTENNA, VRAYLAR, UZEDY, ABILIFY ASIMTUFII, ARISTADA, AUSTEDO XR.
Industry payments across MO — which companies pay providers there.
